Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 43Liver Neoplasms 14Colorectal Neoplasms 11Recurrence 6Cholangiocarcinoma 6Neoplasm Metastasis 5Pancreatic Neoplasms 3Colonic Neoplasms 3Rupture, Spontaneous 2Stomach Neoplasms 1Sarcopenia 1Reperfusion Injury 1Postoperative Complications 1Obesity, Morbid 1Metabolic Syndrome 1Liver Failure 1Klatskin Tumor 1Ischemia 1Hypertension, Portal 1Focal Nodular Hyperplasia 1Fibrosis 1Disseminated Pancreatic Cancer 1Disease Progression 1Conversion Disorder 1Colorectal Cancer Metastatic 1Cirrhosis, Familial, with Pulmonary Hypertension 1Carcinoma 1Abdominal Injuries 1

Interventions

Gemcitabine 11pembrolizumab 10Oxaliplatin 7Nivolumab 7Irinotecan 7Fluorouracil 7Capecitabine 7durvalumab 6Sorafenib 6Leucovorin 6Cyclophosphamide 6Paclitaxel 5Ipilimumab 5tislelizumab 3poly ICLC 3lenvatinib 3fludarabine 3Sunitinib 3Radiotherapy 3Cisplatin 3Cetuximab 3130-nm albumin-bound paclitaxel 3seocalcitol 2selinexor 2pemigatinib 2futuximab 2fludarabine phosphate 2donafenib 2cemiplimab 2atezolizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma × Hepatectomy × Gastrointestinal × Clear all
NCT02102971 2019-09-25

Observational Study of Biomarker During Liver Surgery

University of Florida

Terminated
41 enrolled
Gastrointestinal

Carcinoma, Ischemia, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡